LONDON (Reuters) - European makers of emergency allergy treatments are stepping up production of alternative life-saving adrenaline shots to try to fill intermittent shortages of Mylan's market-leading EpiPen injection.
from Reuters: Health News https://ift.tt/2KSdL0f
0 Comments